Toplum Bilgilendirme
Annals of Oncology - Temmuz 2010
Reviews
Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients
Ann Oncol (2010)21(7):1395-1403published ahead of print January 29, 2010 doi:10.1093/annonc/mdp598
Taking care of smoker cancer patients: a review and some recommendations
Ann Oncol
(
2010
)
21
(
7
):
1404
-
1409
published ahead of print
January 20, 2010
doi:
10.1093/annonc/mdp599
ORIGINAL ARTICLES
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
Ann Oncol (2010)21(7):1411-1418published ahead of print November 30, 2009 doi:10.1093/annonc/mdp552
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
Ann Oncol
(
2010
)
21
(
7
):
1430
-
1435
published ahead of print
January 20, 2010
doi:
10.1093/annonc/mdp585
An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
Ann Oncol
(
2010
)
21
(
7
):
1436
-
1441
published ahead of print
December 23, 2009
doi:
10.1093/annonc/mdp565
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
Ann Oncol (2010) 21(7): 1442-1447published ahead of print November 25, 2009 doi:10.1093/annonc/mdp536
Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
Ann Oncol
(
2010
)
21
(
7
):
1492
-
1499
published ahead of print
December 11, 2009
doi:
10.1093/annonc/mdp544
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
Ann Oncol
(
2010
)
21
(
7
):
1515
-
1522
published ahead of print
December 23, 2009
doi:
10.1093/annonc/mdp573
